Table 1.
Clinical characteristics of the included patients (n = 201). Numbers are shown as % or mean with standard deviation (SD).
| Characteristics | Result (n = 201) | SARS-CoV-2 Vaccination Rate |
|---|---|---|
| Mean age, years | 62.2 ± 14.1 | n.a. |
| Female, n (%) | 133 (66.2) | 110 (82.7) |
| Patients ≥ 60 years, n (%) | 121 (60.2) | 109 (90.1) |
| SARS-CoV-2 vaccination (complete), n (%) | 161 (80.1) | n.a. |
| SARS-CoV-2 vaccination (at least one shot), n (%) | 172 (85.6) | n.a. |
| Influenza vaccination 2020, n (%) | 127 (63.2) | 118 (92.9) |
| Pneumococcal vaccination in the last 5 years, n (%) | 86 (42.8) | 82 (95.3) |
| Rheumatic disease, n (%) | ||
| Rheumatoid arthritis | 89 (44.3) | 74 (83.1) |
| Spondyloarthritis 1 | 55 (27.4) | 51 (92.7) |
| Connective tissue diseases | 41 (20.4) | 33 (80.5) |
| Systemic lupus erythematosus | 34 (82.9) | 27 (79.4) |
| ANCA-associated vasculitis | 11 (5.5) | 10 (90.9) |
| Idiopathic juvenile arthritis | 3 (1.5) | 2 (66.7) |
| Large-vessel vasculitis | 1 (0.5) | 1 (100) |
| Adult-onset Still’s disease | 1 (0.5) | 1 (100) |
1—Including axial spondyloarthritis and psoriatic arthritis.